Abstract
Background In itself, the disease is trivial but rubella in pregnant women may lead to congenital malformations in the baby.
Aims and Objective This study was aimed to determine and analyse the prevalence of rubella antibodies among pregnant women.
Materials and Methods A total of 100 pregnant women were included in this study. Out of 100 pregnant women, 38 cases were from 1st trimester, 35 from 2nd trimester and 27 cases from 3rd trimester. About 2–3 ml of blood sample was collected aseptically from pregnant women at the antenatal clinic and was processed accordingly for detection of IgG and IgM antibodies specific for rubella virus by enzyme-linked immunosorbent assay(ELISA).
Results Out of 100, 94% and 7% of pregnant women were seropositive for anti-rubella IgG and IgM antibodies, respectively. Highest seropositivity for rubella IgG was found in age group 20–25 years (97.61%) followed by 26–30 years (91.89%). Higher seropositivity for rubella IgG antibodies was observed in female residents of rural areas
(94.59%) as compared to those residents of urban areas (93.65%).
Conclusion Prevention of morbidity and mortality from rubella infection depends on prevention of infection in childbearing women and early recognition of maternal infection.
Keywords
References
Ackerknecht EH. A short history of medicine. Baltimore: Johns Hopkins University Press; 1982.
Wesselhoeft C. Rubella and congenital deformities. N Engl J Med. 1949;240(7):258–61.
Banatvala JE, Best JM. Rubella. Topley & Wilson’s, Microbiology and Microbial Infection, 9th ed., vol. 1, Virology. pp.551–77.
Dowdle WR, Ferrera W, De Salles Gomes LF, King D, Kourany M, Madalengoitia J, et al. WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968. Bull World Health Organ.1970;42(3):419–22.
Khare S, Banerjee T, Padudidri V, Rai A, Kumari S. Lowered immunity status of rubella virus infection in pregnant women. J Commun Dis. 1987;19:391–95.
Sridharan G, Ohn TS, Mathai E, Moses PD, Cherian T, Kuruvilla KA, et al. Serology in congenital infections: experience in selected symptomatic infants. Indian Pediatr. 1999;36:667–69.
World Health Organization. Rubella: fact sheet 367. 2012. Available from: http://www.who.int/mediacentre/factsheets/fs367/en.
Jubaida N, Mondal MEA, Kawsar NM. Seroprevalence of rubella antibodies in pregnant women. JAFMC Bangladesh.2011;7(1):20–4.
Olajide OM, Aminu M, Randawa AJ, Adejo DS. Seroprevalence of rubella-specific IgM and IgG antibodies among pregnant women seen in a tertiary hospital in Nigeria. Int J Women’s Health. 2015;7:75–83.
Yadav S, Gupta S, Kumari S. Sero-prevalence of rubella in women of reproductive age group. Indian J Pathol Microbiol. 1995;38:139–42.
Gupta E, Dar L, Broor S. Sero-prevalence of rubella in pregnant women in Delhi, India. Indian J Med Res. 2006;123:833–35.
Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 2: vaccination against rubella. Bull World Health Organ. 1997;75: 69–80.
Kharal SA, Khan MA. Prevalence of rubella seropositivity at successive stages of pregnancy. Pak Armed Forces Med J. 1997;47(1):11–4.
Islam N. The poor’s access to urban land for housing. Urban land. Management in Bangladesh. Government of Bangladesh: Ministry of Land. 1992;131–40.
Mwambe B, Mirambo MM, Mshana SE, Massinde AN, Kidenya BR, Michael D, et al. Sero-positivity rate of rubella and associated factors among pregnant women attending antenatal care in Mwanza, Tanzania. BMC Pregnancy Childbirth. 2014;14:95.
Désinor OY, Ansèlme RJ, Laender F, Saint-Louis C, Bien-Aimé JE. Seroprevalence of antibodies against rubella virus in pregnant women in Haiti. Rev Panam Salud Publica. 2004;15(3):147–50.
Singla N, Jindal N, Aggarwal A. The seroepidemiology of rubella in Amritsar (Punjab). Ind J Med Microbiol. 2004;22(1): 61–3.
Ashrafunnessa, Khatun S, Islam MN, Chowdhury S. Seroprevalence of rubella antibodies among antenatal population attending a tertiary level hospital in Dhaka city. Bangladesh Med Res Counc Bull. 2000;26(3):75–81.
Gupta A, Jain P, Jain A. Sero-prevalence of rubella virus antibodies in pregnant women in vicinity of Lucknow, Uttar Pradesh. Arch Med. 2015;7(3):7.
Adam O, Makkawi T, Kannan A, Osman ME. Seroprevalence of rubella among pregnant women in Khartoum state, Sudan. East Mediterr Health J. 2013;19:812–15.
Malakmadze N, Zimmerman LA, Uzicanin A, Shteinke L, Caceres VM, Kasymbekova K, et al. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001. Clin Infect Dis. 2004;38:1780–783.
Davidkin I, Peltola H, Leinikki P, Valle M. Duration of rubella immunity induced by two-dose measles, mumps, rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine.2000;18:3106–112.
Yasodhara P, Ramalakshmi BA, Naidu AN, Rahman L. Prevalence of specific IgM due to toxoplasma, rubella, CMV and C. trachomatis infections during pregnancy. Indian J Med Microbiol. 2001;19(2):52–56.
Fomda BA, Thokar MA, Farooq U, Sheikh A. Seroprevalence of rubella in pregnant women in Kashmir. Indian J Pathol Microbiol. 2004;47:435–37.
Gandhoke I, Aggarwal R, Lal S, Khare S. Seroprevalence and incidence of rubella in and around Delhi (1988-2002). Indian J Med Microbiol. 2005;23(3):164–67.
Chopra S, Mahajan G. Seroprevalence of rubella antibodies among pregnant women with bad obstetric history in tertiary care hospital. Global J Med Public Health. 2015;4(1).
Yamamoto L, Mejia E, Lopez RM, Gallardo E, Gomez B. Susceptibility to rubella infection in females at high risk. Immune protection associated to population density. Trop Geogr Med. 1995;47(6):235–38.
Gomwalk NE, Ezeronye OU. Sero-epidemiology of rubella in Imo State of Nigeria. Trans R Soc Trop Med Hyg. 1985;79(6):777–80.
Expanded programme on immunization. Rubella outbreak. Wkly Epidemiol Rec. 1994;69:333–36.
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.